SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-199456
Filing Date
2024-08-13
Accepted
2024-08-13 08:58:58
Documents
18
Period of Report
2024-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875997d8k.htm   iXBRL 8-K 36936
2 EX-1.1 d875997dex11.htm EX-1.1 236714
3 EX-4.1 d875997dex41.htm EX-4.1 68960
4 EX-5.1 d875997dex51.htm EX-5.1 19995
8 GRAPHIC g875997dsp41.jpg GRAPHIC 10857
9 GRAPHIC g875997dsp42.jpg GRAPHIC 8428
  Complete submission text file 0001193125-24-199456.txt   606907

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA scph-20240812.xsd EX-101.SCH 2880
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20240812_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20240812_pre.xml EX-101.PRE 11281
20 EXTRACTED XBRL INSTANCE DOCUMENT d875997d8k_htm.xml XML 3623
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 241199011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)